Latest press releases Sep 06 2023 MoonLake Immunotherapeutics to host a Capital Markets Day on Monday, September 11 Aug 10 2023 MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update Jul 25 2023 MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts View All News View All Press Releases + Upcoming events Nov 6 - Nov 7 2023 Guggenheim Securities 5th Annual Inflammation & Immunology Conference Nov 8 - Nov 9 2023 UBS Biopharma Conference 2023 Nov 14 - Nov 16 2023 Jefferies London Healthcare Conference 2023 View All Events View All Events + Corporate presentations Corporate presentation - September 2023 View All Presentations View All Presentations + IR contact details Dr. Atif Khan, Director of Strategic Planning and Projects e: ir@moonlaketx.com
Aug 10 2023 MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
Jul 25 2023 MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts
MoonLake
MoonLake
